Private Market View

Alexander Monro Ziekenhuis

Bilthoven, Netherlands · Founded 2013 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Waterline Capital.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Alexander Monro Ziekenhuis
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Alexander Monro Ziekenhuis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Alexander Monro Ziekenhuis

Operator of a specialized hospital intended to diagnose and treat breast cancer and other related conditions. The company's hospital offers treatment for breast cancer, including chemotherapy and hormone therapy, benign breast conditions, hereditary predisposition, familial risk, screening, and follow-up care based on population screening, plastic surgery, and reconstruction service, enabling patients to access specialized medical care and also ensure early detection of cancer.

Sector
Healthcare
HQ
Bilthoven, Netherlands
Founded
2013
Employees
124
Ownership
Privately Held (backing)
PA Mark — not yet priced

Alexander Monro Ziekenhuis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Alexander Monro Ziekenhuis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Alexander Monro Ziekenhuis in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.